Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse Potential of IV Oxymorphone in Opioid Use Disorder
NCT03389750Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Mar 2018
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oxymorphone in pain, sponsored by New York State Psychiatric Institute. Started Mar 2018; status: completed.
02
Drugs
oxymorphone
03
Conditions
pain
Beyond the preview
Go deeper on NCT03389750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03389750.